MMI completes first robotic-assisted procedure in Alzheimer’s patient

Medical Microinstruments (MMI) announced the completion of the first robotic-assisted procedure in its REMIND U.S. IDE study. REMIND evaluates microsurgical intervention for neurodegenerative disease. MMI...

CVRx enrolls first patient in study of Barostim therapy for heart failure

CVRx announced that it enrolled the first patient in its landmark BENEFIT-HF study of its Barostim therapy. Barostim delivers electrical pulses to baroreceptors in the...

Sensome reports positive findings for clot-sensing guidewire

Sensome announced the publication of first-in-human results from the CLOT OUT study evaluating its Clotild smart guidewire system. Findings published in the Journal of Neurointerventional...

CorTec’s Brain Interchange BCI system enables stroke patient to control computer with his mind

CorTec GmbH announced that the first participant in the University of Washington’s NIH-funded clinical trial of the Brain Interchange™ BCI system has successfully controlled...

LivaNova reports positive findings for sleep apnea neuromod

LivaNova has published 12-month data supporting its proximal hypoglossal nerve stimulation (pHGNS) system for sleep apnea. Findings come from the OSPREY study, which London-based LivaNova...

FeelTect launches vein ulcer monitoring study at University of Galway

FeelTect has kicked off a clinical trial in Ireland to evaluate its wearable, pressure-sensing device for vein ulcers. Researchers at the University of Galway will...

Data supports Boston Scientific Watchman FLX in stroke reduction

Boston Scientific announced new findings from the CHAMPION-AF trial supporting its Watchman FLX system. Watchman FLX, Boston Scientific’s left atrial appendage closure (LAAC) device, reduces...

iPerf enrolls first patient in study of dual-flow femoral artery cannula

iPerf announced the first-in-human use of its new dual-flow femoral arterial cannula device. Lyon, France-based iPerf designed its device to integrate an additional flow...

Providence Medical enrols first patients in CORUS-LX system trial

Providence Medical Technology has enrolled the first subjects in its prospective, randomised controlled trial (RCT) assessing the CORUS-LX system to treat degenerative lumbosacral disease. The...

Latest articles